ALLMedicine™ Hyperbilirubinemia Center

Oct 29th, 2020 - Rebound Bilirubin Levels after Phototherapy in Neonates with Hyperbilirubinemia.|2020|Gordon P,Aldulaimi S,Howe CL,|

Oct 20th, 2020 - Late preterm (LPT) infants are at an increased risk for hyperbilirubinemia. Accurate identification and early treatment are needed for optimal health outcomes. In a newborn nursery at an academic medical center, bilirubin levels were drawn at 24 h...

Oct 19th, 2020 - Phototherapy is the primary treatment for hyperbilirubinemia in neonates. Hypocalcemia is a lesser known but potential detrimental effect of phototherapy. It has been hypothesized that phototherapy inhibits pineal secretion of melatonin, which blo...

Oct 19th, 2020 - The aim was to assess the predictability of transcutaneous bilirubinometry in late preterm and term neonates at risk for pathological hyperbilirubinemia, and to identify the neonatal population in which transcutaneous bilirubin most accurately pre...

Oct 18th, 2020 - Despite widespread phototherapy usage, many new-born infants remain in need of other invasive lines of therapy, such as intravenous immunoglobulins and exchange transfusions. Assessment of the efficacy and the safety of adding fenofibrate to photo...

Sep 29th, 2015 - The antiretroviral protease inhibitor atazanavir inhibits hepatic uridine diphosphate glucuronosyltransferase (UGT) 1A1, thereby preventing the glucuronidation and elimination of bilirubin. Resultant indirect hyperbilirubinemia with jaundice can c...

Sep 28th, 2011 - To standardize the use of phototherapy consistent with the American Academy of Pediatrics clinical practice guideline for the management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Relevant literature was reviewed. P...

Aug 13th, 2010 - Screening of infants for hyperbilirubinemia to prevent chronic bilirubin encephalopathy: recommendation statement.|2010| ,|blood,diagnosis,prevention & control,

Feb 8th, 2010 - Universal screening for hyperbilirubinemia.|2010||blood,blood,diagnosis,standards,

Dec 30th, 2009 - Universal screening for hyperbilirubinemia.|2009| ,|diagnosis,etiology,prevention & control,methods,standards,methods,nursing,standards,

Oct 29th, 2020 - Rebound Bilirubin Levels after Phototherapy in Neonates with Hyperbilirubinemia.|2020|Gordon P,Aldulaimi S,Howe CL,|

Oct 20th, 2020 - Late preterm (LPT) infants are at an increased risk for hyperbilirubinemia. Accurate identification and early treatment are needed for optimal health outcomes. In a newborn nursery at an academic medical center, bilirubin levels were drawn at 24 h...

Oct 19th, 2020 - Phototherapy is the primary treatment for hyperbilirubinemia in neonates. Hypocalcemia is a lesser known but potential detrimental effect of phototherapy. It has been hypothesized that phototherapy inhibits pineal secretion of melatonin, which blo...

Oct 19th, 2020 - The aim was to assess the predictability of transcutaneous bilirubinometry in late preterm and term neonates at risk for pathological hyperbilirubinemia, and to identify the neonatal population in which transcutaneous bilirubin most accurately pre...

Oct 18th, 2020 - Despite widespread phototherapy usage, many new-born infants remain in need of other invasive lines of therapy, such as intravenous immunoglobulins and exchange transfusions. Assessment of the efficacy and the safety of adding fenofibrate to photo...

Mar 1st, 2020 - Some communications among a patient's healthcare team may not be as direct as one would prefer, but they may still trigger a duty on the recipient to follow up. Dr P, a general pediatrician, was called to attend a vaginal delivery of a newborn wit...

Dec 23rd, 2019 - Currently, the multisite MOMPOD trial (Medical Optimization of Management of T2DM Complicating Pregnancy) is randomizing 950 women to insulin plus 1,000 mg metformin twice daily or insulin plus placebo. The primary outcome of the trial is a compos.

Jan 28th, 2019 - The US Preventative Services Task Force, however, found insufficient evidence to recommend universal screening for infants ≥35 weeks’ gestation. 27 The main rationale for their “I” recommendation was that although screening can identify infants at.

May 2nd, 2018 - A randomized, multicenter trial failed to find glyburide noninferior to insulin for treatment of gestational diabetes, investigators reported. The composite rate of macrosomia, neonatal hypoglycemia, and hyperbilirubinemia was 27.

May 2nd, 2018 - WASHINGTON -- Just one dose of a drug called stannsoporfin significantly reduced bilirubin levels in newborns with severe hyperbilirubinemia, but at the potential cost of long-term neurological risk, according to an FDA briefing document prepared ...